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We have examined the role of the membrane-anchoring domain of the HIV-1 glycoproteins in viral glycoprotein function,
glycoprotein incorporation, and viral infectivity. For this purpose, we initially exchanged the entire membrane-spanning
region with that from a cellular glycoprotein (CD22). Subsequently, the strictly conserved arginine in the central position of
the transmembranal alpha-helix was replaced by a neutral residue (R696 r I696). We have further examined the requirements
within the cytoplasmic C-terminus for glycoprotein incorporation and replaced this region of gp160 with the long cytoplasmic
C-terminus (118 amino acids) from CD22. Our results show that the specific amino acid sequence of the membrane-spanning
region of gp160 is not necessary for viral infectivity, thus making it unlikely that this region is specifically involved in
membrane fusion, in glycoprotein incorporation, or in infectivity of the cell lines tested. In contrast, recombinant gp160 with
the CD22 C-terminal region, although present at the cell surface and membrane fusion-competent, was excluded from
incorporation into particles. This could indicate that steric exclusion, and no pseudotyping, occurs when the heterologous,
cytoplasmic C-terminal region is too long and not fitting. q 1996 Academic Press, Inc.
Retroviral particle biogenesis and release do not de- protein and were still infectious, thus suggesting that
other regions of the viral glycoprotein might mediate in-pend on the presence of the viral glycoproteins but when
these are present in the infected or transfected cell, they corporation (3).
The membrane-spanning domains of HIV-1 and otherare specifically incorporated into the lipid bilayer of re-
leased, now infectious particles. The mechanisms and lentiviral TM proteins are unusual in containing a con-
served arginine/lysine residue of unknown function in asignals involved in this process are still poorly under-
stood. Since the matrix protein (MA) is associated central position within the transmembranal alpha-helix
through its N-terminal myristic acid with the inner face (4, 5). It is conceivable that this region, apart from anchor-
of the viral membrane, it should be near the C-terminal ing the envelope protein in the virus membrane, could
domain of the viral glycoprotein. Spatial proximity be- also be involved in specific glycoprotein incorporation. In
tween MA and the transmembranal glycoprotein (TM) previous studies constructs of gp160 containing foreign
was confirmed for Rous sarcoma virus by cross-linking membrane anchors (6) or clustered point mutations (7)
experiments (1). Although it seemed reasonable that the within this region have been analyzed. These, however,
C-terminal region of the viral glycoprotein could be in- were not examined with regard to glycoprotein incorpora-
volved in incorporation, it was demonstrated several tion or virus infectivity.
years ago that removal of this region from Rous sarcoma To investigate the role of the transmembranal domain
virus glycoprotein did not affect incorporation or viral of HIV-1 glycoproteins in viral glycoprotein function, gly-
infectivity (2). The C-terminal domains of lentiviral glyco- coprotein incorporation, and viral infectivity, we initially
proteins are extremely long and in the case of HIV-1 this exchanged the entire membrane-spanning region with
region consists of about 150 amino acids. Although this that from a cellular glycoprotein (CD22) and subsequently
conserved region must certainly have an important in replaced the arginine at position 696 of gp160 with a
vivo function, we could previously demonstrate that HIV- neutral amino acid. We have also further examined the
1 particles encoding truncated glycoprotein with only 7 requirements within the cytoplasmic C-terminus for gly-
cytoplasmic C-terminal amino acids incorporated glyco- coprotein incorporation and replaced this region of
gp160 with the long cytoplasmic C-terminus from CD22
(118 amino acids).1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (49)6221-424932. E-mail: V.Bosch@DKFZ-heidelberg.de. Chimeric env genes were generated, coding for viral
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FIG. 1. Schematic representation (A) and fusion activity (B) of gp160 and chimeric glycoproteins gp160F1-F3. (A) The extracellular (N-terminal),
membrane-spanning, and cytoplasmic (C-terminal) domains are separated by vertical lines and are not drawn to scale. The regions derived from
HIV-1 env are indicated by shaded bars and those derived from CD22 by open bars. The amino acid sequences of the membrane-spanning regions
of gp160 (top) and CD22 (bottom) are shown. The position of the positively charged arginine within the gp160 membrane anchor is indicated. The
chimeric constructs were generated by recombinant PCR (22, 23), fusing sequences from HIV-1 (24) to sequences from CD22 (8); the numbers
represent amino acid positions at the borders of the respective protein sequences (underlined for CD22). In the case of gp160F2, a mutated env
gene with a premature stop codon leads to a C-terminally truncated glycoprotein ending at env amino acid position 712. A further construct,
gp160R696I, in which the basic arginine within the membrane-spanning domain has been changed to isoleucine, was generated by site-directed
mutagenesis using the method of Kunkel (25) as described (3). For expression, the DNA fragments containing the exchanges were cloned via
existing HindIII/XhoI restriction sites into the SV40-based late replacement vector pLExHIVenv or into a proviral construct derived from pNL4-3 (10).
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glycoproteins with exchanges within the transmembranal
region and having various cytoplasmic tails (Fig. 1A). We
chose CD22, a B-cell differentiation antigen (8), as donor
molecule for the respective exchanges. This molecule
has an overall structure similar to that of gp160, with a
highly glycosylated extracellular region, a single mem-
brane anchor of 19 amino acids, and a long cytoplasmic
C-terminus of 118 amino acids.
The chimeric protein gp160F1 contains the TM region
and the complete cytoplasmic tail of CD22. Expression
of glycoprotein from gp160F1 required the coexpression
of a vector expressing the HIV rev protein since, in this
case, the second rev exon at the 3* end of the env gene
has been destroyed. When gp160F1 was expressed with-
out further structural proteins, rev function was provided
by cotransfection with CMV rev (9). gp160F3 contains the
transmembranal region of CD22 and the complete C-
FIG. 2. Western Blot analysis of coexpressed wild-type and chimericterminus of gp160 wild type. gp160F2 is similar to
glycoprotein in HIV-1 particles. COS-7 cells were electroporated with
gp160F3 but contains a stop mutation, resulting in a C- the glycoprotein expression vectors and pK-HIVDenv, a CMV promoter
terminally truncated glycoprotein with 7 instead of the controlled HIV-1 expression vector (12) with a BglII deletion in env (13).
Equal amounts of cell lysates (based on the amount of CA released151 cytoplasmic amino acids of wild-type gp160. To study
into the medium) (A) or centrifuged, lysed virus-like particles (B) werethe effects of the exchanged domains on intracellular
subjected to polyacrylamide gel electrophoresis and Western blottingtransport, cell surface expression, and glycoprotein func-
employing an antiserum against gp120 (3). The respective glycoprotein-
tion, glycoprotein expression vectors (derivatives of expressing constructs employed are marked above each lane. The first
pLExHIVenv, (10)) were transfected in COS-7 cells and lane on the left is a negative control in which cells have been
transfected with expression vector for wild-type HIV-1 glycoproteinsanalyzed in a syncytium assay. As depicted in Fig. 1B,
alone, so that there is no release of virus-like particles into the medium.wild-type gp160 and all of the chimeric gp160 molecules
The positions of gp120 and of wild-type and recombinant gp160 in cellformed similarly sized multinucleated syncytia on coculti-
lysates and of gp120 in pelleted virus-like particles are shown with
vation with CD4/ HeLa cells. This result shows that pro- arrows. The asterisk (*) marks the position of the N-terminal gp120
teolytic activation, intracellular transport to the cell sur- fragment generated from the Env-defective particle producing vector
pK-HIVDenv.face, and the formation of fusion-competent ENV glyco-
protein were still occurring despite the CD22 sequences
in the transmembranal and C-terminal regions of the chi-
type HIV-1 glycoprotein. Recent control experiments withmeric proteins. Although other factors can contribute to
a construct which makes no Env protein at all havecell surface membrane fusion activity, the fact that the
shown that this remaining gp120 fragment is functionallysyncytia were of similar sizes is an indication that surface
inert and has no effect on glycoprotein incorporationexpression of the different constructs is similar.
(data not shown). Two days posttransfection, cell lysatesIn order to investigate glycoprotein incorporation, the
and pelleted particles from media were examined inexpression vectors coding for the chimeric glycoproteins
Western blot (Fig. 2) as to their content of viral glycopro-were cotransfected into COS-7 cells with a plasmid
tein. In order to adjust for differences in transfection effi-which leads to the expression and release of env-defi-
ciencies, the amounts of HIV antigen present in the cen-cient virus-like particles. For this purpose, we employed
trifuged pellets of virus-like particles were determinedpK-HIVDenv, which contains nearly the entire HIV ge-
with an ELISA specific for CA and the volumes of virusnome except nef (nucleotides 221–8887, (11)) under the
particles and cell lysates applied to each lane were ad-control of the CMV promoter (12). A BglII deletion within
justed to represent equal amounts of CA. There was nothe env gene of this vector prevents synthesis of func-
significant effect of the coexpression of the glycoproteintional gp160 (13) but leads to the synthesis of a highly
expression plasmids on virus-like particle release. Figureglycosylated N-terminal gp120 fragment of 281 amino
2A shows an analysis of lysates from cells eitheracids, migrating at about 80 kDa (Fig. 2A, lanes 2–5).
transfected with the wild-type glycoprotein expressionThis component is not found in pelleted virus-like parti-
cles either in the presence or in the absence of wild- vector pLExHIVenv alone (left lane) or cotransfected with
(B) COS-7 cells transfected by electroporation with the glycoprotein expression vector of the constructs indicated and at comparable densities were
cocultivated with an approximately three- to fivefold excess of CD4/ HeLa cells (26) from 24 to 48 hr p.t. Acetone-permeabilized cells were subjected
to indirect immunofluorescence employing anti-gp120 serum (3). The result shown for gp160WT is also representative for gp160R696I. Transfection
with the respective proviral constructs gave comparable results (data not shown).
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pK-HIVDenv and the different wild-type or chimeric con- H9 cells were infected, the same virus mutant was infec-
tious, showing that the phenotype observed was not re-structs. In all cases, two specific bands, not observed in
mock-transfected cells, migrating slower than the 108- stricted to MT-4 cells (data not shown). In contrast,
pNLgp160F2, which in addition to containing the mem-kDa marker, and representing gp120 and the wild-type
or chimeric gp160 moieties, could be detected. The ex- brane anchor of CD22, is truncated within the cyto-
plasmic C-terminus, was completely noninfectious in MT-tent of gp160 cleavage varied somewhat between experi-
ments but was not characteristically reduced for any gly- 4 cells (Fig. 3A) and H9 cells (data not shown). This
result was surprising, since virus containing the samecoprotein construct analyzed (wild-type included). Since
proteolytic cleavage of gp160 most likely occurs in the premature stop codon, but with the membrane anchor of
wild-type gp160, has been shown to be infectious in MT-Golgi complex (14), the presence of gp120 confirms that
intracellular transport has occurred and that the chimeric 4 cells with replication kinetics only marginally delayed
in comparison to wild type (3). It may indicate that inmolecules are substrates for the processing protease.
The gp160 moiety from gp160F1, with a calculated mo- the context of pNLgp160F2, the heterologous membrane-
spanning domain is exerting a deleterious effect. Infectiv-lecular weight not larger than that of gp160, appears to
migrate somewhat slower, which may simply be due to ity of recombinant provirus encoding gp160F1 which
shows no detectable incorporation of gp160F1 into viri-the different amino acid composition of the C-terminus
of this molecule. As expected, the gp160F2 moiety, which ons was not examined since rev function has been de-
stroyed in this mutant. Since pNLgp160F3 demonstratedcontains only 7 C-terminal amino acids, migrates some-
what faster than the other constructs. Figure 2B shows unaltered replication kinetics, it was important to estab-
lish if the decreased amount of particle-associated gp120the results of a Western blot analysis of pelleted virus-
like particles from the cell culture supernatant. In the (observed in virus-like particles released from COS-7
cells, Fig. 2B) could also be seen in particles from in-case of wild-type gp160 and the chimeric constructs
gp160F2 and gp160F3, a single specific band at the posi- fected MT-4 cells. The protein composition of cell lysates,
cell culture supernatants, and pelleted particles was ana-tion of gp120 was detected. The fact that in the cases of
gp160F2 and gp160F3, the amounts of gp120 in purified lyzed after an immunoprecipitation with an AIDS patient’s
serum (15) (Fig. 3). As depicted in Fig. 3B, there was novirus-like particles were clearly lowered compared to
wild type either indicates a loss of functional incorpora- significant effect of the mutation on the amount of cell-
associated virus proteins, so that similar steady-statetion or simply a loss of previously incorporated glycopro-
tein (shedding). In the case of gp160F1, in which both levels of env and gag gene products could be observed.
Corresponding to the results obtained from the cotrans-the TM region and the cytoplasmic tail have been re-
placed with CD22 sequences, particle-associated glyco- fection studies in COS-7 cells (Fig. 2), yet not reflecting
the unimpaired spread in MT-4 cells, the amount ofprotein was not detectable. In the left lane, medium from
cells transfected with pLExHIVenv alone has been ana- gp120 associated with virions pelleted from the superna-
tant of pNLgp160F3-infected cells was clearly lowered.lyzed. This is an important negative control since it can
be seen that in the absence of virus-like particles, there On the basis of four independent experiments it was
calculated that pelleted pNLgp160F3 virus particles con-is no contamination of the pellet from the centrifuged
culture supernatant with soluble gp120 or with cell debris tained a fivefold reduced gp120/p24 ratio as compared
to wild-type HIV-1 (determined by an image-plate scan-containing viral glycoprotein.
Since the chimeric glycoproteins have been shown to ner). The reason for the reduced amount of glycoprotein
in pelleted virus particles is not known, but could be thebe biologically active on the surface of transfected COS-
7 cells and considerable, albeit reduced amounts were result of increased glycoprotein shedding, as it has been
shown for many naturally occurring virus isolates andpresent in virus-like particles, it was interesting to deter-
mine if further glycoprotein functions, necessary for virus several well-studied laboratory isolates of HIV-1 (16). This
possibility is supported by the fact that the amount ofreplication in T-cell lines, were supported. For this pur-
pose, the respective proviral constructs of gp160F2 and gp120 in the culture supernatant was greater in the case
of pNLgp160F3 compared to wild type (Fig. 3B).gp160F3 were generated by using existing HindIII and
XhoI restriction sites in pNLWT (3). After obtaining cell- Exchanging the complete membrane-anchoring amino
acids of gp160 seemed to affect the stability of the viralfree virus stocks from transiently transfected COS-7 cells,
MT-4 cells were infected with equal amounts of virus as glycoprotein complex. This phenotype could be due to
the absence of the positively charged amino acid withindetermined in a capsid ELISA (3). In the case of
pNLgp160F3, in which only the membrane anchor of the membrane anchor of the chimeric proteins that is
otherwise present in a central position in all HIV TMgp160 has been exchanged with that from CD22, there
is no significant impact on the infection kinetics (Fig. proteins. For this reason we changed arginine 696 to
isoleucine and analyzed the effect of the mutation on3A). While in this experiment virus spread of pNLWT
appeared to be slightly decreased compared to pNL- glycoprotein function and on particle association of the
viral glycoprotein. COS-7 cells were transfected with agp160F3, this has not been a consistent finding. When
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FIG. 3. Infection of MT-4 cells with pNLWT and the virus-mutants pNLR696I, pNLgp160F2, and pNLgp160F3. Infection kinetics (A) and viral
proteins (B and C), after immunoprecipitation of proteins from the cell lysate, the cell culture medium before centrifugation, or of pelleted particles.
(A) Equal amounts of virus from the supernatant of transfected COS-7 cells were used to infect 1–5 1 105 MT-4 cells. One day postinfection cells
were washed and particle release was followed employing a p24 ELISA (3). The numbers given at the ordinate are arbitrary ELISA units. (B, C)
After labeling 1 1 106 infected MT-4 cells for 18 hr with 500 mCi [35S]cysteine, released virus was centrifuged through a cushion of 20% sucrose
(15), and cell, medium and virus lysates were immunoprecipitated with an AIDS patient serum and analyzed as described before (10).
proviral construct either coding for wild-type (pNLWT) or However, despite the comparable replication kinetics,
pNLR696I exhibited clearly reduced amounts of particle-mutant glycoprotein (pNLR696I). Wild-type and mutant
glycoproteins were present at the cell surface in amounts associated gp120 (Fig. 3C), similar to the results obtained
with gp160F3 (Fig. 3B).sufficient to form similarly sized multinucleated syncytia
on cocultivation with CD4/ HeLa cells. This result shows Although retroviral particle assembly and release can
occur normally in the absence of viral glycoproteins, inthat the mutation has presumably not affected cell sur-
face expression and fusion activity. To study if the re- their presence, these components are incorporated into
virions. The basis for this process is still unknown. Origi-leased virus particles were infectious, virus replication
in MT-4 cells was followed by a capsid ELISA. No striking nally it seemed reasonable that an interaction between
the matrix protein and the spatially proximal cytoplasmicdifference in infection kinetics (Fig. 3A) or cytopathic ef-
fect (not shown) could be observed. It has been reported C-terminus or membrane anchor of the retroviral TM pro-
tein could confer this specificity. Analysis of MA pointthat changing arginine 696 to serine had a moderately
negative influence on infectivity, measured in a single- mutations have clearly demonstrated that MA is involved
in glycoprotein incorporation. However, recently it hasround infection assay (17, 18). This is a discrepancy to
the observations presented here, but it may indicate an been shown that these same MA mutants which fail to
incorporate wild-type glycoproteins with a bulky C-termi-effect of the mutation on cell-free infection, which is not
evident in an infected MT-4 culture, when virus spread nus can still incorporate C-terminally truncated glycopro-
tein. The doubly mutated virus is in fact still infectiousis predominantly supported by cell to cell infection.
Particles released from infected MT-4 cells were also (19, 20). This indicates that the MA framework may not
be actively selecting for the components of the virusanalyzed to determine their protein composition and the
amount of glycoprotein in pelleted virus particles (Fig. membrane but rather simply be excluding molecules with
C-termini which do not fit. This would be the case with3C). For this purpose, cell lysates and pelleted virus parti-
cles from the supernatant of infected metabolically la- gp160F1 that contains 118 foreign cytoplasmic amino
acids and was not incorporated into virus-like particlesbeled MT-4 cells were immunoprecipitated with an AIDS
patient’s serum. Infection with both viruses resulted in (Fig. 2B).
The dispensability of the cytoplasmic C-terminus forthe production of comparable amounts of viral proteins in
the cell lysate, and the absence of the positively charged glycoprotein incorporation (gp160F2, this study and our
previous results (3)) points to the putative active compo-amino acid in the membrane-anchoring region had no
effect on cleavage, indicating an unaltered transport and nent in this process not being located within the cyto-
plasmic tail of the viral glycoprotein. In order to study thean unimpaired accessability by the cellular protease.
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